Orthometrix Operating Margin from 2010 to 2026
| OMRX Stock | USD 0.0001 0.00 0.00% |
Check Orthometrix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Orthometrix's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 521.5 K or Total Revenue of 916.7 K, as well as many indicators such as Price To Sales Ratio of 1.58, Dividend Yield of 0.0 or Days Sales Outstanding of 87.84. Orthometrix financial statements analysis is a perfect complement when working with Orthometrix Valuation or Volatility modules.
Orthometrix | Operating Margin | Build AI portfolio with Orthometrix Stock |
Latest Orthometrix's Operating Margin Growth Pattern
Below is the plot of the Operating Profit Margin of Orthometrix over the last few years. It is Orthometrix's Operating Profit Margin historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Orthometrix's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (1.85) % | 10 Years Trend |
|
Operating Profit Margin |
| Timeline |
Orthometrix Operating Margin Regression Statistics
| Arithmetic Mean | 0.12 | |
| Geometric Mean | 0.17 | |
| Coefficient Of Variation | 107.02 | |
| Mean Deviation | 0.08 | |
| Median | 0.17 | |
| Standard Deviation | 0.13 | |
| Sample Variance | 0.02 | |
| Range | 0.4212 | |
| R-Value | 0.58 | |
| Mean Square Error | 0.01 | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | 0.02 | |
| Total Sum of Squares | 0.27 |
Orthometrix Operating Margin History
About Orthometrix Financial Statements
Orthometrix investors use historical fundamental indicators, such as Orthometrix's Operating Margin, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Orthometrix. Please read more on our technical analysis and fundamental analysis pages.
Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. Orthometrix, Inc. was founded in 1993 and is headquartered in Naples, Florida. Orthometrix operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 7 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Orthometrix Stock Analysis
When running Orthometrix's price analysis, check to measure Orthometrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthometrix is operating at the current time. Most of Orthometrix's value examination focuses on studying past and present price action to predict the probability of Orthometrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthometrix's price. Additionally, you may evaluate how the addition of Orthometrix to your portfolios can decrease your overall portfolio volatility.